Literature DB >> 20170292

Trends in the survival of patients diagnosed with cancers in the respiratory system in the Nordic countries 1964-2003 followed up to the end of 2006.

Timo Hakulinen1, Gerda Engholm, Mette Gislum, Hans H Storm, Asa Klint, Laufey Tryggvadóttir, Freddie Bray.   

Abstract

BACKGROUND: Previous studies have shown that there have been systematic differences between the Nordic countries in population-based relative survival of patients with respiratory cancer (lung, pleura, larynx, nose and sinuses).
MATERIAL AND METHODS: Relative survival of patients with respiratory cancer diagnosed in the Nordic countries in 1964-2003 and followed up to the end of 2006 was studied and contrasted with developments in incidence and mortality.
RESULTS: For cancer of the lung, relative survival is lower in Danish patients than in the other countries during the first months of follow-up after diagnosis. For cancer of pleura, the relative survival ratios indicate that there may be problems in the official coding of the causes of death in Denmark, Norway and Sweden. There has been little improvement in survival of patients with cancer of the respiratory organs in the Nordic countries over time.
CONCLUSIONS: The slightly lower survival of Danish lung cancer patients may be related to a less favourable stage distribution and to an increased prevalence of causal factors, affecting the mortality due to competing risks of death. A reclassification of official causes of death at the cancer registry may be needed for cancer of the pleura in order to make the corresponding mortality rates comparable between countries.

Entities:  

Mesh:

Year:  2010        PMID: 20170292     DOI: 10.3109/02841860903575281

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  7 in total

1.  [Laryngeal carcinoma: epidemiology, risk factors and survival].

Authors:  M Pantel; O Guntinas-Lichius
Journal:  HNO       Date:  2012-01       Impact factor: 1.284

2.  Incidence and survival in laryngeal and lung cancers in Finland and Sweden through a half century.

Authors:  Anni Koskinen; Otto Hemminki; Asta Försti; Kari Hemminki
Journal:  PLoS One       Date:  2022-05-27       Impact factor: 3.752

3.  Revising Incidence and Mortality of Lung Cancer in Central Europe: An Epidemiology Review From Hungary.

Authors:  Krisztina Bogos; Zoltán Kiss; Gabriella Gálffy; Lilla Tamási; Gyula Ostoros; Veronika Müller; László Urbán; Nóra Bittner; Veronika Sárosi; Aladár Vastag; Zoltán Polányi; Zsófia Nagy-Erdei; Zoltán Vokó; Balázs Nagy; Krisztián Horváth; György Rokszin; Zsolt Abonyi-Tóth; Judit Moldvay
Journal:  Front Oncol       Date:  2019-10-23       Impact factor: 6.244

4.  Estimating and validating disability-adjusted life years at the global level: a methodological framework for cancer.

Authors:  Isabelle Soerjomataram; Joannie Lortet-Tieulent; Jacques Ferlay; David Forman; Colin Mathers; D Maxwell Parkin; Freddie Bray
Journal:  BMC Med Res Methodol       Date:  2012-08-17       Impact factor: 4.615

5.  The direct and indirect impact of comorbidity on the survival of patients with non-small cell lung cancer: a combination of survival, staging and resection models with missing measurements in covariates.

Authors:  Maria Iachina; Anders Green; Erik Jakobsen
Journal:  BMJ Open       Date:  2014-02-12       Impact factor: 2.692

6.  Age and Gender Specific Lung Cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016.

Authors:  Lilla Tamási; Krisztián Horváth; Zoltán Kiss; Krisztina Bogos; Gyula Ostoros; Veronika Müller; László Urbán; Nóra Bittner; Veronika Sárosi; Aladár Vastag; Zoltán Polányi; Zsófia Nagy-Erdei; Andrea Daniel; Balázs Nagy; György Rokszin; Zsolt Abonyi-Tóth; Judit Moldvay; Zoltán Vokó; Gabriella Gálffy
Journal:  Pathol Oncol Res       Date:  2021-04-30       Impact factor: 3.201

7.  Improvement in Lung Cancer Survival: 6-Year Trends of Overall Survival at Hungarian Patients Diagnosed in 2011-2016.

Authors:  Krisztina Bogos; Zoltan Kiss; Lilla Tamási; Gyula Ostoros; Veronika Müller; László Urbán; Nóra Bittner; Veronika Sárosi; Aladár Vastag; Zoltán Polányi; Zsófia Nagy-Erdei; Andrea Daniel; Zoltán Vokó; Balázs Nagy; Krisztián Horváth; György Rokszin; Zsolt Abonyi-Tóth; Zsófia Barcza; Gabriella Gálffy; Judit Moldvay
Journal:  Pathol Oncol Res       Date:  2021-04-30       Impact factor: 3.201

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.